Codone Biotechnology
PrivateCompany Overview
Codone Biotechnology operates in Healthcare & Life Sciences and is based in Shanghai. It was founded in 2022.
Codone Biotechnology is a biotechnology company that develops transformative medicines based on suppressor-tRNAs for patients with severe diseases caused by premature termination codons.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Codone Biotechnology Comparables
Compare Codone Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alltrna | 87% | |
| Tevard Biosciences | 86% | |
| Shape Therapeutics | 74% |
For institutional investors. Book with your work email.
Codone Biotechnology Funding Rounds
Historical fundraising activity
Codone Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Codone Biotechnology's valuation, stock price, and market status.
Is Codone Biotechnology a public or private company?
Codone Biotechnology is a private company.
What is the current stock price of Codone Biotechnology?
Codone Biotechnology is a private company, so its shares have no public market price. Caplight tracks Codone Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Codone Biotechnology worth (valuation)?
Valuation information for Codone Biotechnology is not publicly available.
Can I buy Codone Biotechnology stock?
Codone Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Codone Biotechnology's last funding round?
Funding round information for Codone Biotechnology is not publicly available.
Who are the main investors in Codone Biotechnology?
Investor information for Codone Biotechnology is not publicly disclosed.
Will Codone Biotechnology IPO soon?
No public IPO plans have been announced for Codone Biotechnology.
How can I track Codone Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Codone Biotechnology's shares on secondary markets.